XML 58 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Investments
3 Months Ended
Mar. 31, 2014
Regulated Entity, Other Assets, Noncurrent [Abstract]  
Other Investments
Other Investments
Nuclear Decommissioning Trusts
Future decommissioning costs of removal of SCE's nuclear assets are expected to be funded from independent decommissioning trusts, which currently receive contributions of approximately $23 million per year through SCE customer rates. Contributions to the decommissioning trusts are reviewed every three years by the CPUC.
The following table sets forth amortized cost and fair value of the trust investments:
 
Longest
Maturity
Dates
 
Amortized Cost
 
Fair Value
(in millions)
 
March 31,
2014
 
December 31,
2013
 
March 31,
2014
 
December 31, 2013
Stocks
 
$
668

 
$
656

 
$
2,234

 
$
2,208

Municipal bonds
2051
 
725

 
675

 
838

 
756

U.S. government and agency securities
2044
 
812

 
902

 
864

 
947

Corporate bonds
2054
 
253

 
208

 
296

 
241

Short-term investments and receivables/payables
One-year
 
342

 
329

 
355

 
342

Total
 
 
$
2,800

 
$
2,770

 
$
4,587

 
$
4,494


Trust fund earnings (based on specific identification) increase the trust fund balance and the ARO regulatory liability. Proceeds from sales of securities (which are reinvested) were $1.50 billion and $435 million for the three months ended March 31, 2014 and 2013, respectively. Unrealized holding gains, net of losses, were $1.79 billion and $1.72 billion at March 31, 2014 and December 31, 2013, respectively.
The following table sets forth a summary of changes in the fair value of the trust:
 
 
Three months ended March 31,
(in millions)
 
2014
 
2013
Balance at beginning of period
 
$
4,494

 
$
4,048

Gross realized gains
 
10

 
5

Gross realized losses
 

 
(1
)
Unrealized gains, net
 
62

 
176

Other-than-temporary impairments
 
(3
)
 
(8
)
Interest, dividends, contributions and other
 
24

 
26

Balance at end of period
 
$
4,587

 
$
4,246


Due to regulatory mechanisms, earnings (including other-than-temporary impairments) and realized gains and losses have no impact on operating revenue or earnings.